The NYC Venture Capital Firm News Digest: 02/15/2022

0

twelve below

$50 million fund I

Twelve Below, a NYC-focused seed fund, raised $50 million for its inaugural fund. The firm was founded by New York investment veteran Taylor Greene, who previously held positions at Collaborative Fund and Lerer Hippeau. The fund, which was founded in July, already has companies like Acrrue Savings, Otto, Dutech and Opentrons in its portfolio.

TQ Ventures

$12.5M Early Fund III First Closing | $37.5M Growth Fund III First Closing

TQ Ventures, the early-stage and growth-stage investment firm, led the first closing of two new funds according to a recent SEC filing. The filing indicates that the fund offer for the initial fund is $125 million and $375 million for the growth fund, both closings had one hundred LPs. TQ Ventures was founded by Andrew Marks, Schuster Tanger and Scooter Braun in 2018. The portfolio includes Latch, Vertical Finance, Liquid IV, Right Rice, Ro, Mos, Modern Treasury, TrialSpark, Zype, Current, Clubhouse and Noom. The company closed Fund II in 2019.

NowRx is disrupting the $480 billion retail pharmacy industry with unprecedented personalized service and free same-day pharmacy delivery. The company uses its proprietary “QuickFill” pharmacy software and robotics to automate prescription dispensing and reduce common service failures that lead to bad customer experiences (insurance errors, out of stock, etc.). Oh, and they work at a fraction of the cost of large retail chains – let’s talk about efficiency! In 2020, the company saw its revenue jump 90% year-over-year and this year it is on track to surpass over $22 million in revenue. With their new telehealth product growing 73% per month and a stock price that’s up 1,650% since 2016, this is an investment you don’t want to miss. Step into this growing startup and find out how you can invest today

Grace Isford

Main | Capital Lux

Grace Isford has joined Lux ​​Capital as a Director with a focus on Web3, Data Infrastructure and AI/ML. She joins the company after spending more than 5 years at Canvas Ventures, where she invested in companies like airvet, Flowspace, Conduktor, Flyhomes and Robocorp. Isford graduated from Stanford.

Imaginary companies

$270 Million Fund III | $175 million Growth Fund III

Imaginary, the startup and growth investment firm focused on the intersection of retail and technology, has closed two new funds according to a recent SEC filing. The filing indicates that the main fund has seventy-one LPs and the growth fund has sixty-six backers. Imaginary Ventures was founded by Natalie Massenet and Nick Brown in 2018. The portfolio includes Skims, SIMULATE, Glossier, Keeps, HUM Nutrition and NuORDER. The company closed Fund II in 2019.

Have an impact on your results and generate leads!

AlleyWatch audiences drive global progress and innovation. There are a number of options to reach this audience of the world’s most innovative organizations and startups, including strategic brand placement, lead generation, and thought leadership in front of an audience that includes the vast majority of major decision makers in the New York area. community and beyond. Learn more about advertising at NYC Tech, at scale.

J Ventures

Fund II deposit – $45 million

J Ventures, an early-stage technology fund, is raising its second fund according to a recent SEC filing. The record indicates that the total offer is $45 million. J Ventures was founded by John Nordin and Joshua Jacobson in 2019. The company’s portfolio includes names such as bbot, Brighhire, Ro, Clear, Ramp, Sprout and Troops.

Black opal companies

Fund I deposit – $120 million

Black Opal Ventures, a health technology-focused investment fund, is raising its first fund according to a recent SEC filing. The record indicates that the total offer is $120 million. J Ventures was founded by doctor-turned-investor Tara Bishop. The company’s portfolio includes names such as bbot, Brighhire, Ro, Clear, Ramp, Sprout and Troops.

You’re seconds away from joining NYC Tech’s hottest list!

register today

NowRx is disrupting the $480 billion retail pharmacy industry with unprecedented personalized service and free same-day pharmacy delivery.

The company uses its proprietary “QuickFill” pharmacy software and robotics to automate prescription dispensing and reduce common service failures that lead to bad customer experiences (insurance errors, out of stock, etc.).

Oh, and they work at a fraction of the cost of large retail chains – let’s talk about efficiency!

In 2020, the company saw its revenue jump 90% year-over-year and this year it is on track to surpass over $22 million in revenue. With their new telehealth product growing 73% per month and a stock price that’s up 1,650% since 2016, this is an investment you don’t want to miss.

Share.

About Author

Comments are closed.